Angela Webster, MBBS, talks about why only certain patients should be screened for cancer post-transplant.
Obese individuals often are rejected as renal transplant candidates in large part because of their increased risk for surgical complications and adverse outcomes.
Pre-existing renal osteodystrophy at the time of transplantation, reduced renal function, and transplantation-specific therapies are the main contributing factors.
Biopsies are of little value in determining overall risk of delayed organ function or even premature organ failure, researcher says.
By age 80 years, the estimated lifetime risk of ESRD was 90 per 10,000 live donors compared with 326 per 10,000 in the general population.
Sitagliptin was well tolerated and it significantly increased insulin secretion and reduced glucose levels.
Levels above 500 ng/mL predicted higher incidence rates of infections overall as well as bacterial and bloodstream infections.
Renal tissue could one day be created that would be functional as well as completely immunocompatible.
HIV-1 was found in podocytes or tubular cells of renal allografts in recipients who did not have detectable plasma levels of the virus.
Increasing age and receipt of a deceased-donor kidney were among risk factors for death from infection.
Complications and hospital lengths of stay after kidney donation declined from 10.1% and a mean 3.7 days, respectively.
In a study, only 8% of readmissions within 30 days of discharge met preventability criteria.
'Even 100 days out the risk is still high and it is still going higher,' researcher says.
Researchers evaluated sulfamethoxazole-trimethoprim single-strength twice-weekly in abdominal organ transplant patients.
Presence of complement-binding donor-specific antibodies increases risk of graft loss.
High risker of biopsy-proven acute rejection and death-censored graft failure observed in patients with a BMI of 35 kg/m2 or greater.
Even after five years on the drug, patients continue to have improved renal function compared with patients receiving cyclosporine A.
Cidofovir cleared cytomegalovirus that was resistant to ganciclovir.